Registry of Acute Coronary Syndromes in the Lazio Region of Italy

NCT ID: NCT01216462

Last Updated: 2015-05-21

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

3000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2010-01-31

Study Completion Date

2018-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The NET-SCA Registry has been designed to document and evaluate the clinical epidemiology and current management of Acute Coronary Syndromes in the Lazio Region of Italy.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Lazio is a region of central Italy with a resident population of about 5,600,000. The NET-SCA Registry has been designed to document and evaluate the current presentation and clinical management of Acute Coronary Syndromes (ACS) in this specific regional area of Italy. All consecutive patients with ACS admitted to CCU of 15 hospitals of the Lazio Region will be included in the registry.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Acute Coronary Syndromes

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* admission to CCU for ACS

Exclusion Criteria

* ACS due to major extracardiac causes (i.e. traumatic)
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Associazione Nazionale Medici Cardiologi Ospedalieri

OTHER

Sponsor Role collaborator

San Filippo Neri General Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Furio Colivicchi

Director, Division of Cardiology, San Filippo Neri General Hospital, Rome, ITALY

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Furio Colivicchi, MD

Role: PRINCIPAL_INVESTIGATOR

San Filippo Neri Hospital, Rome, Italy

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Ospedale "G.B. Grassi"

Rome, Italy, Italy

Site Status RECRUITING

San Filippo Neri Hospital

Rome, Italy, Italy

Site Status RECRUITING

Ospedale "S. Eugenio"

Rome, Italy, Italy

Site Status RECRUITING

Ospedale "Sandro Pertini"

Rome, Italy, Italy

Site Status RECRUITING

Policlinico Casilino

Rome, Italy, Italy

Site Status RECRUITING

Ospedale "Madre Giuseppina Vannini"

Rome, Italy, Italy

Site Status RECRUITING

Ospedale FBF "Isola Tiberina"

Rome, Italy, Italy

Site Status RECRUITING

Ospedale GG Grassi

Ostia Antica, Roma, Italy

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Italy

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Furio Colivicchi, MD

Role: CONTACT

+39.06.3306.1 ext. 2429

Marco Tubaro, MD

Role: CONTACT

+39.06.3306.1 ext. 2467

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Fabrizio Ammirati, MD

Role: primary

Furio Colivicchi, MD

Role: primary

+39.06.3306.1 ext. 2429

Marco Tubaro, MD

Role: backup

+39.3306.1 ext. 2467

Achille Gaspardone, MD

Role: primary

Giuseppe Ferraiuolo, MD

Role: primary

Ernesto Lioy, MD

Role: primary

Gerardo Ansalone, MD

Role: primary

Paolo Azzolini, MD

Role: primary

Fabrizio Ammirati, MD

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

SFN/117/09/AL

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

The Euro-CRAFT Registry
NCT05805462 ACTIVE_NOT_RECRUITING
INOCA Spanish National Registry
NCT06327672 RECRUITING